Published in J Oral Maxillofac Surg on June 01, 2012
Transpalatal advancement pharyngoplasty for obstructive sleep apnea: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol (2016) 0.75
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma. Mayo Clin Proc (2006) 2.88
Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol (2009) 2.37
Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol (2010) 2.12
BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. Nat Cell Biol (2009) 2.04
Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells (2010) 1.98
Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin Cancer Res (2007) 1.78
Comparative analysis of traditional radiographs and cone-beam computed tomography volumetric images in the diagnosis and treatment planning of maxillary impacted canines. Am J Orthod Dentofacial Orthop (2010) 1.66
Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial. Cancer Prev Res (Phila) (2013) 1.50
A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett (2009) 1.49
Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res (2010) 1.41
Re: Drage NA, et al. Hemangioma of the body of the mandible: a case report. Br J Oral Maxillofac Surg 2003; 41: 112-114. Br J Oral Maxillofac Surg (2003) 1.38
Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol Cancer Ther (2006) 1.34
Sources of variation in baseline gene expression levels from toxicogenomics study control animals across multiple laboratories. BMC Genomics (2008) 1.33
Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin Cancer Res (2007) 1.32
Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. Neurosurgery (2006) 1.23
Characterization of craniomaxillofacial battle injuries sustained by United States service members in the current conflicts of Iraq and Afghanistan. J Oral Maxillofac Surg (2010) 1.23
Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis. J Bone Joint Surg Am (2004) 1.23
Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res (2007) 1.22
Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic. Environ Health Perspect (2010) 1.21
Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther (2005) 1.18
Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR. Toxicol Sci (2008) 1.13
Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis. Stem Cells Dev (2011) 1.12
Treatment with siRNA and antisense oligonucleotides targeted to HIF-1alpha induced apoptosis in human tongue squamous cell carcinomas. Int J Cancer (2004) 1.12
Fatal rhino-orbito-cerebral zygomycosis caused by Apophysomyces elegans in a healthy patient. J Oral Maxillofac Surg (2006) 1.12
Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis. PLoS One (2009) 1.12
Guidelines for the prevention of infections associated with combat-related injuries: 2011 update: endorsed by the Infectious Diseases Society of America and the Surgical Infection Society. J Trauma (2011) 1.07
Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells. Int J Cancer (2010) 1.06
Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation. Arthritis Rheum (2013) 1.05
Dental characteristics of fibrous dysplasia and McCune-Albright syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2003) 1.05
Guidelines for the prevention of infection after combat-related injuries. J Trauma (2008) 1.04
Morphologic evaluation and classification of facial asymmetry using 3-dimensional computed tomography. J Oral Maxillofac Surg (2011) 1.03
Evaluation of orthodontic mini-implant anchorage in premolar extraction therapy in adolescents. Am J Orthod Dentofacial Orthop (2008) 1.02
Perspectives on the role of nanotechnology in bone tissue engineering. Dent Mater (2012) 1.01
Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett (2005) 1.00
Anthropometric analysis of the human mandibular cortical bone as assessed by cone-beam computed tomography. J Oral Maxillofac Surg (2009) 0.99
Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity? J Oral Maxillofac Surg (2007) 0.98
Human gingiva-derived mesenchymal stromal cells attenuate contact hypersensitivity via prostaglandin E2-dependent mechanisms. Stem Cells (2011) 0.98
Hypoxia-induced HIF-1 alpha accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: involvement of ERK1/2 and PI-3K/Akt. Exp Cell Res (2005) 0.98
Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol (2003) 0.98
Application of a facial injury severity scale in craniomaxillofacial trauma. J Oral Maxillofac Surg (2006) 0.97
Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma. Cancer (2006) 0.97
Plates, screws, and children: their relationship in craniomaxillofacial trauma. J Long Term Eff Med Implants (2003) 0.96
Etk/Bmx mediates expression of stress-induced adaptive genes VEGF, PAI-1, and iNOS via multiple signaling cascades in different cell systems. Am J Physiol Cell Physiol (2005) 0.96
2007 research summit: at the forefront of innovation. J Oral Maxillofac Surg (2008) 0.96
Green tea extract and (-)-epigallocatechin-3-gallate inhibit mast cell-stimulated type I collagen expression in keloid fibroblasts via blocking PI-3K/AkT signaling pathways. J Invest Dermatol (2006) 0.96
Injectable reactive biocomposites for bone healing in critical-size rabbit calvarial defects. Biomed Mater (2012) 0.95
Evaluation of the human airway using cone-beam computerized tomography. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.95
Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg (2008) 0.95
Arsenic and Environmental Health: State of the Science and Future Research Opportunities. Environ Health Perspect (2015) 0.94
Activation of NFkappaB signal pathways in keloid fibroblasts. Arch Dermatol Res (2004) 0.93
Comparison of pharyngeal airway changes on plain radiography and cone-beam computed tomography after orthognathic surgery. J Oral Maxillofac Surg (2011) 0.93
Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol (2003) 0.93
Role of tissue engineering in oral and maxillofacial reconstruction: findings of the 2005 AAOMS Research Summit. J Oral Maxillofac Surg (2005) 0.92
IL-17-mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws. Clin Cancer Res (2013) 0.91
Tissue banking in head and neck cancer. Oral Oncol (2007) 0.91
Effect of osteoporotic status on the survival of titanium dental implants. Int J Oral Maxillofac Implants (2008) 0.91
Characterization of dental epithelial stem cells from the mouse incisor with two-dimensional and three-dimensional platforms. Tissue Eng Part C Methods (2012) 0.90
Intraosseous venous malformation of the mandible: a review on interdisciplinary differences in diagnostic nomenclature for vascular anomalies in bone and report of a case. J Oral Maxillofac Surg (2011) 0.90
Nanotechnology approaches to improve dental implants. Int J Oral Maxillofac Implants (2011) 0.90
Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers. Cancer Lett (2005) 0.88
Crosstalk of hypoxia-mediated signaling pathways in upregulating plasminogen activator inhibitor-1 expression in keloid fibroblasts. J Cell Physiol (2004) 0.87
Craniofacial fibrous dysplasia. Oral Maxillofac Surg Clin North Am (2012) 0.86
Hypertension: classification, pathophysiology, and management during outpatient sedation and local anesthesia. J Oral Maxillofac Surg (2006) 0.86
In vitro characterization of scaffold-free three-dimensional mesenchymal stem cell aggregates. Cell Tissue Res (2014) 0.86
Pediatric maxillary odontogenic myxoma: a report of 2 cases and review of management. J Oral Maxillofac Surg (2008) 0.85
A novel 3-dimensional culture system as an in vitro model for studying oral cancer cell invasion. Int J Exp Pathol (2005) 0.85
Nanotechnology for dental implants. Int J Oral Maxillofac Implants (2013) 0.85
Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1α and VEGF expression in non-small cell lung cancer cells. Cancer Lett (2011) 0.85
Computer-aided stereolithography for presurgical planning in fibula free tissue reconstruction of the mandible. J Reconstr Microsurg (2012) 0.84
Current thoughts on treatment of patients receiving anticoagulation therapy. J Oral Maxillofac Surg (2010) 0.84
The α7nACh-NMDA receptor complex is involved in cue-induced reinstatement of nicotine seeking. J Exp Med (2012) 0.84
Temporary anchorage device insertion variables: effects on retention. Angle Orthod (2010) 0.84
Susceptibility of older adults to health effects induced by ambient air pollutants regulated by the European Union and the United States. Aging Clin Exp Res (2013) 0.84
Prevention and management of infections associated with combat-related head and neck injuries. J Trauma (2008) 0.83
Dietary selenium intake and genetic polymorphisms of the GSTP1 and p53 genes on the risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2006) 0.83
Mesenchymoma: an unusual tumour of the lip. Br J Oral Maxillofac Surg (2004) 0.83
The influence of mechanical environment on bone healing and distraction osteogenesis. Atlas Oral Maxillofac Surg Clin North Am (2008) 0.83
Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 0.82
Development of imiquimod-loaded mucoadhesive films for oral dysplasia. J Pharm Sci (2012) 0.82
Green tea induces annexin-I expression in human lung adenocarcinoma A549 cells: involvement of annexin-I in actin remodeling. Lab Invest (2007) 0.82
Management of atrophic mandible fractures: are bone grafts necessary? J Oral Maxillofac Surg (2010) 0.81
Knowledge, attitudes, practices, and training needs of Kentucky dentists regarding violence against women. Gen Dent (2007) 0.80
Comparison of the severity of bilateral Le Fort injuries in isolated midface trauma. J Oral Maxillofac Surg (2005) 0.80
The endoscopic brow and midface lift. Atlas Oral Maxillofac Surg Clin North Am (2003) 0.80
Natural large-scale regeneration of rib cartilage in a mouse model. J Bone Miner Res (2015) 0.80
Kinematic study of the temporomandibular joint in normal subjects and patients following unilateral temporomandibular joint arthrotomy with metal fossa-eminence partial joint replacement. J Oral Maxillofac Surg (2007) 0.79
Characterization of skin allograft use in thermal injury. J Burn Care Res (2013) 0.79
The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures. J Am Dent Assoc (2004) 0.79
Neuroleptics antagonize nalbuphine antianalgesia. J Pain (2006) 0.78
Immunohistochemical analysis of cortical and cancellous bone after radiation and the effect of platelet-rich plasma on autogenous bone grafting. Int J Oral Maxillofac Implants (2006) 0.78
A subanalgesic dose of morphine eliminates nalbuphine anti-analgesia in postoperative pain. J Pain (2008) 0.78
Retracted Ossifying fibroma tumor stem cells are maintained by epigenetic regulation of a TSP1/TGF-β/SMAD3 autocrine loop. Cell Stem Cell (2013) 0.78
Prevention of infections associated with combat-related eye, maxillofacial, and neck injuries. J Trauma (2011) 0.78
Complications of frontal sinus fractures with emphasis on chronic craniofacial pain and its treatment: a review of 43 cases. J Oral Maxillofac Surg (2010) 0.77
Abstracts from the American Association Of Oral And Maxillofacial Surgeons annual scientific meeting: proportion published and time to publication. J Oral Maxillofac Surg (2005) 0.77
Addiction Research Centres and the Nurturing of Creativity. Substance abuse research in a modern health care centre: the case of the Centre for Addiction and Mental Health. Addiction (2011) 0.77
Operative utilization following severe combat-related burns. J Burn Care Res (2015) 0.77
COMPETING PROPERTIES OF MUCOADHESIVE FILMS DESIGNED FOR LOCALIZED DELIVERY OF IMIQUIMOD. Biomater Sci (2013) 0.77
Treatment of arteriovenous malformation of the mandible with resection and immediate reconstruction. J Oral Maxillofac Surg (2009) 0.77
Biocomposites of pHEMA with HA/β -TCP (60/40) for bone tissue engineering: Swelling, hydrolytic degradation, and in vitro behavior. Polymer (Guildf) (2012) 0.77